Fingerprint
Dive into the research topics of 'Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically